AbbVie
ABBV
#30
Rank
ยฃ339.15 B
Marketcap
ยฃ191.96
Share price
4.20%
Change (1 day)
42.25%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of March 2026 : ยฃ103.39 Billion

According to AbbVie's latest financial reports the company's total assets are ยฃ103.39 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2026)

Total assets by year

Year Total assets Change
2025-12-31ยฃ99.47 B-7.65%
2024-12-31ยฃ107.70 B1.86%
2023-12-31ยฃ105.73 B-7.84%
2022-12-31ยฃ114.73 B5.69%
2021-12-31ยฃ108.55 B-1.73%
2020-12-31ยฃ110.46 B62.54%
2019-12-31ยฃ67.95 B45.34%
2018-12-31ยฃ46.75 B-10.73%
2017-12-31ยฃ52.37 B-2.23%
2016-12-31ยฃ53.56 B49.64%
2015-12-31ยฃ35.79 B102.57%
2014-12-31ยฃ17.67 B-0.17%
2013-12-31ยฃ17.70 B5.93%
2012-12-31ยฃ16.70 B33.05%
2011-12-31ยฃ12.55 B-8.26%
2010-12-31ยฃ13.69 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
ยฃ157.31 B 52.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ88.32 B-14.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ70.08 B-32.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ22.33 B-78.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ42.64 B-58.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ65.52 B-36.63%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ86.38 B-16.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ63.08 B-38.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ3.71 B-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA